PMID: 1688102Jan 1, 1991Paper

Propranolol and thyroid hormone metabolism

Thyroid : Official Journal of the American Thyroid Association
W M Wiersinga


Propranolol decreases plasma T3 and increases plasma rT3 in a dose-dependent manner due to a decreased production rate of T3 and a decreased metabolic clearance rate of rT3, respectively, caused by inhibition of the conversion of T4 into T3 and of rT3 into 3,3'-T2. This inhibition of 5'-deiodination is not secondary to inhibition of thyroid hormone transport across the plasma membrane. Propranolol and its major metabolite, 4-hydroxypropranolol, are not directly responsible for these effects, but an unidentified metabolite of propranolol might be involved. beta-blockers ameliorate clinical symptoms and signs of thyrotoxicosis independent of the decrease of plasma 13, that is confined to beta-blockers with membrane-stabilizing activity, such as propranolol and alprenolol. The decrease of plasma T3, however, appears responsible for some of the metabolic responses to beta-blockers.


Sep 1, 1976·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·U B LauridsenJ Nerup
Mar 1, 1978·The Journal of Clinical Endocrinology and Metabolism·C W ZwillichJ V Weil
Sep 1, 1978·British Journal of Clinical Pharmacology·D G McDevitt, J K Nelson
Dec 1, 1979·British Journal of Clinical Pharmacology·L E MurchisonP D Bewsher
Jan 1, 1979·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J FaberP Theilade
Apr 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·I Andersen
May 1, 1979·Clinical Endocrinology·J FeelyJ Crooks
May 1, 1979·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·C J van NoordenJ L Touber
Dec 1, 1979·The Journal of Clinical Investigation·A S JenningsR D Utiger
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R P VerhoevenM A Schalekamp
Jul 1, 1978·Clinical Endocrinology·J SaundersP H Sönksen
Feb 1, 1978·Endocrinology·P ChiraseveenuprapundI N Rosenberg
Oct 1, 1975·British Journal of Clinical Pharmacology·J K Nelson, D G McDevitt
Aug 1, 1977·The Journal of Clinical Endocrinology and Metabolism·W M Wiersinga, J L Touber
Dec 1, 1977·Clinical Pharmacology and Therapeutics·B O Kristensen, J Weeke
Apr 1, 1990·Journal of Endocrinological Investigation·L KayserJ E Hansen
Mar 1, 1990·Clinical Endocrinology·O EberP Költringer
May 1, 1985·Postgraduate Medical Journal·M R WilkinsM J Kendall
Feb 1, 1985·Clinical Pharmacology and Therapeutics·R A ReevesF H Leenen
Jan 27, 1973·Lancet·M G Gibberd, J S Staffurth
Jul 1, 1969·Acta Endocrinologica·D R HaddenJ A Weaver
Apr 1, 1981·Postgraduate Medical Journal·M K JonesM Lewis
Jun 1, 1982·British Journal of Clinical Pharmacology·N R PedenJ Crooks
Dec 1, 1982·The American Journal of Medicine·D S CooperE C Ridgway
Sep 1, 1980·Clinical Endocrinology·J HowP D Bewsher
Dec 1, 1981·Clinical Endocrinology·S KaurI Ramsay
Oct 1, 1980·European Journal of Clinical Pharmacology·O R NilssonL Tegler

❮ Previous
Next ❯


Oct 23, 1998·Molecular and Cellular Endocrinology·M R StulpC Ris-Stalpers
Mar 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lars P KlieverikAndries Kalsbeek
Feb 19, 2008·Thyroid : Official Journal of the American Thyroid Association·J Enrique Silva, Suzy D C Bianco
Sep 5, 2014·Journal of Endocrinological Investigation·Michele MarinòPaolo Vitti
Mar 27, 2012·The Medical Clinics of North America·Joanna Klubo-Gwiezdzinska, Leonard Wartofsky
Apr 6, 2006·Clinical Techniques in Small Animal Practice·Lauren A Trepanier
Jul 22, 2014·The Korean Journal of Internal Medicine·Dong Hun KimSoon-Pyo Hong
Nov 3, 2016·International Journal of Endocrinology·Arnaldo Moura Neto, Denise Engelbrecht Zantut-Wittmann
May 5, 2017·Health Services Insights·Marcia Rashelle Palace
Jan 1, 1994·Thyroid : Official Journal of the American Thyroid Association·M WalkerP Kendall-Taylor
Nov 24, 2018·Environmental Science and Pollution Research International·Shakila SabirAmmara Saleem
Feb 13, 2019·The Journal of Clinical Endocrinology and Metabolism·James E HaddowGlenn E Palomaki
Jun 19, 2001·American Journal of Physiology. Endocrinology and Metabolism·J BurggraafH Pijl
Oct 13, 2020·Annals of Clinical Biochemistry·David J Halsall, Susan Oddy

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
Susanne NeumannMarvin C Gershengorn
Annals of Internal Medicine
A Rizvi, L M Crapo
European Journal of Endocrinology
Fereidoun Azizi, Atieh Amouzegar
© 2021 Meta ULC. All rights reserved